Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 7,500 shares on February 12, with a total net reduction of 60,300 shares over the past five trading days and 210,300 shares over the past twenty trading days [1] - As of now, southbound funds hold 5,645,200 shares of Gaoshi Medical, accounting for 3.81% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: self-owned products, distribution, technical services, and others [1] - The self-owned products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1] - The distribution segment sells multifunctional diagnostic equipment, fundus diagnostic, surgical, and treatment equipment produced by other ophthalmic medical device manufacturers, along with related consumables [1] - The technical services segment provides warranty, maintenance, and after-sales services along with consumables used for these services [1] - The other segment mainly includes granting intellectual property rights and providing clinical research organization-related services [1]
高视医疗（02407.HK）：2月12日南向资金减持7500股